These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 29233895)

  • 1. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
    Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
    Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
    Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
    Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
    mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CRISPR AcrIE2 Binds the Type I-E CRISPR-Cas Complex But Does Not Block DNA Binding.
    Mejdani M; Pawluk A; Maxwell KL; Davidson AR
    J Mol Biol; 2021 Feb; 433(3):166759. PubMed ID: 33338493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
    Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
    J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity.
    Li R; Fang L; Tan S; Yu M; Li X; He S; Wei Y; Li G; Jiang J; Wu M
    Cell Res; 2016 Dec; 26(12):1273-1287. PubMed ID: 27857054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine Cleavage System and cAMP Receptor Protein Co-Regulate CRISPR/
    Yang D; Wang Z; Ma J; Fu Q; Wu L; Wang H; Wang S; Yan Y; Sun J
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31941083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Subcellular Localization of a Type I CRISPR Complex and the Cas3 Nuclease in Bacteria.
    Govindarajan S; Borges A; Karambelkar S; Bondy-Denomy J
    J Bacteriol; 2022 May; 204(5):e0010522. PubMed ID: 35389256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The solution structure of an anti-CRISPR protein.
    Maxwell KL; Garcia B; Bondy-Denomy J; Bona D; Hidalgo-Reyes Y; Davidson AR
    Nat Commun; 2016 Oct; 7():13134. PubMed ID: 27725669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR RNA and anti-CRISPR protein binding to the
    Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
    J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Type I-F Anti-CRISPR Protein Inhibits the CRISPR-Cas Surveillance Complex by ADP-Ribosylation.
    Niu Y; Yang L; Gao T; Dong C; Zhang B; Yin P; Hopp AK; Li D; Gan R; Wang H; Liu X; Cao X; Xie Y; Meng X; Deng H; Zhang X; Ren J; Hottiger MO; Chen Z; Zhang Y; Liu X; Feng Y
    Mol Cell; 2020 Nov; 80(3):512-524.e5. PubMed ID: 33049228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
    Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
    Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature, by Controlling Growth Rate, Regulates CRISPR-Cas Activity in Pseudomonas aeruginosa.
    Høyland-Kroghsbo NM; Muñoz KA; Bassler BL
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.
    Pawluk A; Bondy-Denomy J; Cheung VH; Maxwell KL; Davidson AR
    mBio; 2014 Apr; 5(2):e00896. PubMed ID: 24736222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
    Radovčić M; Čulo A; Ivančić-Baće I
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system.
    Bondy-Denomy J; Pawluk A; Maxwell KL; Davidson AR
    Nature; 2013 Jan; 493(7432):429-32. PubMed ID: 23242138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
    Majsec K; Bolt EL; Ivančić-Baće I
    BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How bacteria control the CRISPR-Cas arsenal.
    Leon LM; Mendoza SD; Bondy-Denomy J
    Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.